Back to search

Article

Mutations in genes <i>lpxL1, bamA</i> and <i>pmrB</i> impair the susceptibility of cystic fibrosis strains of <i>Pseudomonas aeruginosa</i> to murepavadin

2023-10-13

Abstract excerpt

Murepavadin is a peptidomimetic exhibiting specific inhibitory activity against Pseudomonas species. In the present study, its in vitro activity was assessed on 230 cystic fibrosis (CF) strains of P. aeruginosa isolated from twelve French hospitals, in comparison with twelve other antipseudomonal antibiotics. Although murepavadin is still in pre-clinical stage of development, 9.1% ( n =21) of the strains displ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21098af2-d8e6-507a-a109-f5ba93235801
DOI
10.1101/2023.10.09.561565
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mutations in genes <i>lpxL1, bamA</i> and <i>pmrB</i> impair the susceptibility of cystic fibrosis strains of <i>Pseudomonas aeruginosa</i> to murepavadinDOI 10.1101/2023.10.09.561565
Select a neighboring publication to make it the new centre.